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Abstract:
Bionix® Medical Technologies employed us to reconsider their design flaws in their currently marketed
ShotBlocker® product. The intended injection molded design (low-density polyethylene) utilizes the gate
control theory of pain management by firmly pressing against the surrounding injection site to saturate the
sensory signals. There are contact points (little spikes) on the underside of the ShotBlocker®, and those
contact points overstimulate the patient’s nerves as to where the needle is being inserted making it hard to
distinguish when and where the actual needle is being injected, thus lessoning anxiety. Studies have been
completed by Amer, Barnhill, Gueverra, and more that illustrate pain perception reduction in patients
using the ShotBlocker® device for subcutaneous injections.
Disposability is a major issue with this product, as physicians or nurses are re-using a single
ShotBlocker® with only light sterility. To increase demand and open the market for this product, a new
design following the problem statement was needed. Our team, Dolorvacare, took this project to establish
a ShotBlocker® that keeps the same intended purpose of saturating pain signals, but also increases use
and disposability. After guidance from Bionix®, we were looking to combine the ShotBlocker® with a
safety needle, which is inherently disposable. No particular design preference was discussed, as our
meetings debated ideas for a spring or hinge on the current product.
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INTRODUCTION
Bionix® Medical Technologies employed us to reconsider their design flaws in their currently marketed
ShotBlocker® product. The intended injection molded design (low-density polyethylene) utilizes the gate
control theory of pain management by firmly pressing against the surrounding injection site to saturate the
sensory signals. There are contact points (little spikes) on the underside of the ShotBlocker®, and those
contact points overstimulate the patient’s nerves as to where the needle is being inserted making it hard to
distinguish when and where the actual needle is being injected, thus lessoning anxiety. Studies have been
completed by Amer, Barnhill, Gueverra, and more that illustrate pain perception reduction in patients
using the ShotBlocker® device for subcutaneous injections [1-5].

Figure (1). ShotBlocker® Standard
Design as sold by Bionix®

Our problem statement was derived after meeting with Bionix® and discussing the issues with the current
design:
“A ShotBlocker® device is available for trypanophobic (needle-fearing) patients or children to reduce
pain and anxiety by utilizing pressure to relieve the surrounding injection site. Although the
ShotBlocker’s® original purpose was achieved, usage has shown a few additional problems to face. The
ShotBlocker® is intended to be used one-time only, and in a medical setting are often being reused. To
promote regular disposability, to eliminate time and resources of sanitizing and reusing the shot blocker,

and to keep the original, simple purpose of the existing ShotBlocker®, the ShotBlocker® needs to be
attached to a prepackaged syringe and sold as one entity. The design should be inexpensive, simple to use,
purposeful, and disposable.”
Disposability is a major issue with this product, as physicians or nurses are re-using a single
ShotBlocker® with only light sterility. To increase demand and open the market for this product, a new
design following the problem statement was needed. Our team, Dolorvacare, took this project to establish
a ShotBlocker® that keeps the same intended purpose of saturating pain signals, but also increases use
and disposability. After guidance from Bionix®, we were looking to combine the ShotBlocker® with a
safety needle, which is inherently disposable. No particular design preference was discussed, as our
meetings debated ideas for a spring or hinge on the current product.

BACKGROUND INFORMATION
As seen in Figure 1, the current ShotBlocker® already exists and is sold in packages of 50 ($34.95) or
100 ($49.95). Research studies have been conducted regarding the already marketed ShotBlocker®
device that have illustrated efficacy in the clinical setting by utilizing pressure to reduce the pain at/near
injection sites. A particular pain scale was used in each study (Gueverra, Manila Doctors, Emerg) to help
decipher the ShotBlocker’s® effectiveness. There have been issues with hospitals reusing the device
instead of making use of its disposability. As hospitals are reimbursed for their “patient satisfaction”
metrics, pain and anxiety reduction from injections is a marketable undertaking. In order to promote
disposability, a new design is needed to implement a safety needle as a single combinatory package. Our
team has thoroughly investigated the product and identified the flaws pertaining to the problem statement
in order to design a more proficient product. During the second meeting, we discussed ideas based on
hinges or springs to apply into the current device to create a combinatory package with the safety needle.
We found the average price for intramuscular injections was $22.45 according to a study done by Colwell
CW et al [6]. We also discussed with a local nurse, Audrey, on prices regarding the syringes/needles,

which are bought in large quantity boxes. Advertisement seems like another issue, as she has never seen
or heard of this product, but was readily willing to use it for needle-fearing patients and saw where it
could easily fit into her hospitals day to day usages. Hospitals would readily profit from using the
ShotBlocker® by its cheap cost in combination with the standard intramuscular or subcutaneous
injections. They would also be reimbursed for the increased “patient satisfaction.” When selling to nurses
or doctors, a simple design is needed to not overcomplicate the product use, seeing as many injections are
given each day.
Using the 0-6 Baker-Wong pain scale, with 0 signifying no pain and 6 signifying extreme pain, research
has shown statistically significant pain reduction via the ShotBlocker® with various control tests
conducted on kindergarten and adult patients as seen below [1] [3].

Figure (2) (3). Statistics Regarding Pain Scores of Conducted Studies w/ without ShotBlockers ® [1] [3]

PROJECT OBJECTIVES, GOALS, METHODS/MANUFACTURING
Our company, Dolorvacare created a mission statement regarding our project objectives:
“At Dolorvacare Medical, our goal is to provide pain-reducing solutions for medical staff, home
caretakers, and anyone who could be spared from unnecessary pain. We are continually searching for new
ways to reduce needle and other common anxieties patients may face. From shot-blockers to needle
guards, we offer disposable products that are both reliable and affordable, providing a one of a kind value
to our customers.”

Our main project objectives were to design a new ShotBlocker® for better marketability with an
attachment that can allow combinatory packaging with a safety needle. This will cause the physician to
not be put-off by a more complicated design, although we also wish to also pursue our potential second
design [Figure 5,6]. We met our objective per Bionix’s® request by establishing a design [Figure 4] with
a two piece assembly clip that can be manufactured via 3D Printing or Injection Molding. If 3D Printed,
Nylon 6/6 holds the same initial product flexibility to produce the sensory saturation effects. Two pieces
would be needed for the clip design to be injection molded with low-density polyethylene. Injection
molding would be cheaper and more efficient in the long-run due to costs of 3D plastic and injection
methods.
Team meetings with/without Bionix® helped us establish a re-design utilizing the proper methods.
Modeling the new design in SolidWorks off of a ShotBlocker® fitting a 3ml syringe we were able to
analyze the Nylon 6/6 material and LDPE material with FEA (finite element analysis). Following these
procedures we procured information regarding the maximum stress areas and pliability, along with safety
factors that determined functionality of the device. Our initial objective tree was followed in pursuit of
our established project design. Our goals were met through our team methods and software capabilities.

Figure (4). Dimensionally Correct ShotBlocker® Redesign for 3D Printing w/ Nylon 6/6 Plastic

Design 2 Considerations/Objectives/Goals:
After our clip idea was on route to be prototyped, this gave us time to spare and look into a more
complicated and innovative solution. We were wary to go in this direction after so much feedback from
nurses and physicians about keeping the design simple, but after input from Bionix® and more brain
storming, we came up with a second potential solution to our problem statement.
One end of the needle guard will one-time-snap into the clip of the ShotBlocker®, making it a valuable
part of a safety needle, protecting the user from an accidental prick. This will permanently lock the part
into the assembly and will encourage discarding after use. The other end of the needle guard will be
designed to fit various syringe sizes. The syringe will sit into the needle guard and may also have a onetime-snap lock to encourage throwing the assembly away as a whole unit. The entire assembly will,
ideally, lock as one unit and will not come apart. Example draft sketched below. Further design
considerations needed.

[Needle Guard]

[Assembly]

Figure (5) (6). Illustrations of Complex Design

PERFORMANCE TESTING
Defining our forces and more FEM analysis on Design #1
We decided to use a force meter from the physics lab to gauge the approximate force that would be put on
the wings of the ShotBlocker®. This is valuable both for analysis of our first design, and for analysis of
our second design’s plausibility (to make the second design we would need to thicken the ShotBlocker®,

but would still want it to be able to be flexible enough to contour to the patient when used). In the trial,
we zeroed the force meter at the beginning, then tested the force meter by pulling on it, then applied the
approximate force you would use on the wings of the ShotBlocker®. If anything, our force ranged on the
side of being stronger than you would press into a patient.

Figure (7). Force vs time graph to gauge what forces we should use

From this force, we entered it into our original FEA analysis of the clip. By applying the 18N max force
as a pressure analysis on the inner surface of the clip, we can assess the displacement of the clip when
attaching the syringe and if any deformation is present on the Nylon 6/6 plastic [Figure 9]. First off, to set
the boundary conditions, the bottom of the ShotBlocker® was fixed in all three dimensions to obtain
correct clip displacement. As seen below [Figure 8], the clip has two maximum displacements near the
top of the 18N ( ~4 lb*F) applied pressure. The maximum von mises stresses are also seen [Figure 12,
13]. To calculate a safety factor, the maximum yield stress was taken as a ratio over the obtained von
mises stresses. The safety factor never reached below 1, yielding sufficient results for non-lasting
deformation of the Nylon 6/6 material from the finite element analysis [Figure 10]. Because of the
material being ductile, we used the maximum yield stress of 46 N/mm^2 over the ultimate tensile strength
of 76 N/mm^2 of the Nylon 6/6 material.

Figure (8) (9). Boundary Conditions and FEA Setup, Along with Clip Displacement

Figure (10). Calculated Safety Factor

FEA was conducted again with only the bottom middle section being constrained. This was to see the
displacement of the wings for material flexibility. The material must be able to contour around the arm to
serve its product purpose. The same conditions were used, with only the constraints changed [Figure 11].
The maximum displacements are seen below in figure 7, showing material flexibility. Furthermore, the
maximum von mises stresses were also seen near the clip and wings. The safety factor was calculated
again using the maximum yield stress of 46 N/mm^2, with none of the ShotBlocker’s® area going below
1.

Figure (11) – Displacement of Second FEA

Concluding the analysis, we can ultimately say that the chosen material is ductile enough to serve its
original purpose with the clip attached. No lasting deformation should be present with the newly printed
material.

Figure (12) (13) – Nodal Analysis of Stress, Displacement, and Safety Factors for First Two FEA

FEM analysis before pursuing Design #2
Before pursuing Design 2, we decided to test how the ShotBlocker® would perform with a thicker middle
section. To produce design 2, we would need a thicker middle section for it to meet the structural needs of
being a needle clip as well. However, if a thicker middle section impedes the ability for the ShotBlocker®
to flex and contour to the curvature of the injection site, we lose the original purpose of the ShotBlocker®
and will not pursue this Design.

Figure (12). 18N Surface Applied Force on New ShotBlocker® Model

The finite element analysis was conducted on the new model with a thicker middle-section near the clip
(1.0mm to 2.09mm). The same boundary conditions were used as the previous testing along with the
maximum applied force from the meter applied over the top surface (18N) [Figure 12]. As seen in the
figure below, the maximum displacement was obtained on the wings of the ShotBlocker®. This is in
alignment with the previous conclusion, but the model must be further changed to attach the hinge for a
proper analysis. The contour can be obtained from the FEA information that was obtained. Nylon 6/6 is
therefore determined to be a suitable material for our 3D printed model. The factor of safety was also seen
to be above 2, with no plastic deformation present after the applied force. Max von mises stress near the
middle area of the ShotBlocker® was also miniscule as seen in the below nodal data.

Figure (13) (14) (15). Displacement, Von Mises, and Safety Factor Visuals for 18N Surface Force Over
ShotBlocker® Wings

maxdisp2
Load case 1 of 1Displacement Magnitude (mm)Node # 2174, X = 28.1957, Y = -35.87, Z = 2.84261, Val = 1.2256

maxstress1
Load case 1 of 1Stress von Mises (N/(mm^2)) Layer Number = WorstPart# 1, Element# 5153, Element Node# 2,
Node# 922, X = -3.10393, Y = -13.1001, Z = 1, Val 20.3495
Node# 1, Node# 922, X = -3.10393, Y = -13.1001, Z = 1, Val 20.3495

maxstress2
Load case 1 of 1Stress von Mises (N/(mm^2)) Layer Number = WorstPart# 1, Element# 9293, Element Node# 2,
Node# 916, X = 3.06929, Y = -12.6917, Z = 1, Val 18.6684
Part# 1, Element# 10243, Element Node# 1, Node# 916, X = 3.06929, Y = -12.6917, Z = 1, Val 18.6684

maxsafetyfactor
Load case 1 of 1Stress von Mises Layer Number = WorstPart# 1, Element# 2075, Element Node# 3, Node# 3283,
X = -15.2066, Y = -18.5836, Z = 1, Val 25.7121
Part# 1, Element# 2194, Element Node# 6, Node# 3283, X = -15.2066, Y = -18.5836, Z = 1, Val 25.7121

As seen in Figure 12, the minimum safety factor that was seen was 2.0642. Being greater than 1, we can
make the assumption that our new design won’t experience any plastic deformation due to the max stress
of 18N obtained from the force meter.

FUTURE DIRECTIONS
After performing an FEM analysis on the thicker model and confirming it would not impede the quality,
we are now going to also pursue our second design as well. Next we are going to be drafting the new
design in SolidWorks. As we pursue design #2 as well, we will continue to work on our original clip
design. We are currently waiting on our prototype for design #1 to arrive. Once we have our clip
prototype, we hope present it to a panel of nurses and compare it to the original along with a sketch of our
new design, seeing which they like best and feel they would use. Once we have design #2 sketched out,
we will run an FEM (finite element method) analysis on the design. With only one month left, we will
work to get a prototype printed of our second design as well.
Once we receive the first Plastic Nylon 6/6 prototype from ShapeWays we will conduct physical
performance testing using our purchased force meter to detect maximum stress forces. Being a strong and
flexible plastic (nylon 6/6), after initial FEM testing, it should be flexible enough to contour around the
patient’s arm and maintain rigidity.

FUNCTIONAL REQUIREMENTS
Our ShotBlocker® clip design followed the below tree on functional requirements [Figure 16]. The
largest requirement fulfilling the purpose of our project was disposability. This was achieved with the
packaging of the safety needle, causing inadvertent disposing of the whole package after use. The
reliability will be the same due to the bottom contact points remaining in our design. Placing the product
on the patient firmly is the only operation to use our product making it very ergonomic. Due to the
options of 3D printing with Nylon 6/6 or injection molding in a two piece method with LDPE, the design
is cost effective in manufacturing.

Figure 16. Function Requirements

CONSTRAINTS AND LIMITATIONS
Many constraints and limitations were placed on both our complex hinge design and clip design.
Some pros of our clip design are illustrated below:









Single assembly
Prevents pain and is safe
LDPE is a low cost material, if injection molded
Easy to produce
Disposable
Clip and shot blocker are both made of LDPE, if injection molded
Syringe easily clips on/off
Simple design
o Requires little to no training to use
o No preparation other than removing product from package; doesn't take extra time out of
user's day

The constraints/limitations for the clip design are also listed below:





May need different sized clips to accommodate different syringe sizes
Multiple molds may be expensive
New packaging to fit both syringe and shot blocker
Syringe can easily unclip from shot blocker in package

In general, our clip design suffers from the constraints of making new molds if injection molding for
manufacturing. It also suffers from the new packaging that must fit both the ShotBlocker ® and safety
needle/syringe. If 3D printed, the company would also need to buy new machinery.
Our hinge complex design is still needing to be tested but offers some new variability of pros:








Eliminates accidental needle prick completely
Entire product still made of LDPE
Disposable
Displacement needle tracks how much of a needle enters patient
Bodily fluid hazard reduced
Rigid components place more pressure around needle stick area
Nerve stimulation not affected by more complicated design

While there are still constraints/limitations present regarding this design:









Possibly too expensive to produce
Too many components
Requires more preparation than users may want to deal with
Flexibility lost for stability
LDPE material may not support load
Requires two new molds
New packaging
Must be used when snapped together

TIMELINE
Initial Timeline:
Task
Project Binder-Spring Semester
Team Member Expectations
Team Mission Statement rewrite
Problem Statement rewrite
Objective Tree rewrite
Team Meeting Schedule Organization
Follow up with Bionix on objectives
Guntt chart through may
Read Journal Articles from Bionix
Discuss and Decide a weekly meeting
time for
Spring Semester

Start Date
Duration
End Date
9/15/14
81
12/5/14
10/25/14
8
11/2/14
11/15/14
15
11/30/14
11/15/14
15
11/30/14
11/15/14
15
11/30/14
11/20/14
7
11/27/14
11/25/14
5
11/30/14
11/25/14
6
12/1/14
11/27/14
4
12/1/14

12/8/14

12

Column1
All
All
Arianna
Sam
Brandon
Tori
Tori
Tori
All

12/20/14 All

Schedule a meeting with
Supervisor for Progress Reports. A
formal report and updated GANTT chart
is required

1/1/15

32

2/2/15 All

Final Notebook to be finished during
final exam period
Begin First drafts of design

1/1/15
1/15/15

120
7

5/1/15 All
1/22/15 All

Decide on top Designs to submit to
Bionix

1/22/15

7

1/29/15 All

Type up results, limitations, constraints
and goals
Risk Assesment
System design Review

1/29/15
1/29/15
1/29/15

7
7
1

2/5/15 All
2/5/15 All
1/30/15 All

2/2/15
2/5/15
2/10/15

28
7
7

3/2/15 All
2/12/15 All
2/17/15 All

2/17/15

57

4/15/15 All

3/2/15

35

4/6/15 All

Schedule a meeting with
Supervisor for Progress Reports. A
formal report and updated GANTT chart
is required
Material Selection
Planning for Actual Production
Follow Plan for Actual Production of
a prototype
Schedule a meeting with
Supervisor for Progress Reports. A
formal report and updated GANTT chart
is required

Final Timeline:

BUDGET
Our budget for the project mandated by the rubric was $500. We easily stayed under this budged, with our
purchases and spending begin minimal. We purchased two prototypes from ShapeWays of two different
nylon materials, both costing around $12 dollars each. We also purchased a force meter for FEM analysis
usage. It was difficult for us to find them on campus, and using the physics lab was a hindrance to their
program. A force meter online was $15 dollars and we will continue to use it. Invoices for these three
things are all in order.
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